Literature DB >> 6889747

Catatonic behavior induced by haloperidol, increased by retesting and elicited without drug in rats.

L F de Sousa Moreira, M C Pinheiro, J Masur.   

Abstract

The catatonogenic action of haloperidol in rats was assessed through different experimental procedures. In the first experiment the animals were injected intraperitoneally with haloperidol, 0.4-4.0 mg/kg, and then divided into two subgroups. The first group was tested for catatonic behavior from 20 min up to 4 h after the injection, while the second was only tested throughout the last 3- to 4-hour period. In the second experiment, animals received, either 0.2 or 0.6 mg haloperidol/kg 3 times at 15-day intervals, and were tested for catatonic behavior from 20 to 240 min after the injection. 15 days after the last drug session, the same animals were injected with distilled water and then tested for catatonia. The results showed that retesting drastically influenced the amount of catatonic behavior and that, when under no drug, the rats still displayed catatonia. The data suggest a learning component of this behavior.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6889747     DOI: 10.1159/000137716

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  4 in total

1.  Differences in the cataleptogenic actions of SCH23390 and selected classical neuroleptics.

Authors:  A S Undie; E Friedman
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

2.  The selective dopamine antagonist properties of BRL 34778: a novel substituted benzamide.

Authors:  F Brown; W Campbell; M S Clark; D S Graves; M S Hadley; J Hatcher; P Mitchell; P Needham; G Riley; J Semple
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

3.  Temporal Factors Modulate Haloperidol-Induced Conditioned Catalepsy.

Authors:  Lucía Cárcel; Luis G De la Casa
Journal:  Front Behav Neurosci       Date:  2021-07-02       Impact factor: 3.558

4.  Conditioned increase of locomotor activity induced by haloperidol.

Authors:  Luis Gonzalo De la Casa; Lucía Cárcel; Juan Carlos Ruiz-Salas; Lucía Vicente; Auxiliadora Mena
Journal:  PLoS One       Date:  2018-10-03       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.